Let's Connect

News

Ahead of the FDA Action Date: A Timeline of Igalmi for Agitation in Bipolar Disorder and Schizophrenia

By Industry News 1 min read

​Review the timeline for Igalmi in at-home treatment of agitation in bipolar disorder and schizophrenia.  — From Psychiatric Times articles Read More

Share this post
All News posts
News Industry News 12:00 pm Adopting New Voices: Supporting Nonspeaking Patients After Brain Injury ​Many traumatic brain injuries result in significant communication impairment across a spectrum that can range from limited speaking to apparent disorders of consciousness such as comas.  — From Psychiatric Times articles Read More News Industry News 10:00 am Closing Diagnostic and Treatment Gaps in Black Children With ADHD ​Explore how ADHD diagnosis and treatment adherence is unique for Black children.  — From Psychiatric Times articles Read More News Industry News 9:00 am Evaluating Bright Light Therapy for Nonseasonal Depression: A Systematic Review and Meta-Analysis ​Meta-analysis finds bright light therapy boosts remission and response in nonseasonal depression, offering a low-cost add-on to standard care.  — From Psychiatric Times articles Read More

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Follow us

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.